Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection JOURNAL OF HEPATOLOGY Li, Y., Chang, M., Abar, O., Garcia, V., Rowland, C., Catanese, J., Ross, D., Broder, S., Shiffman, M., Cheung, R., Wright, T., Friedman, S. L., Sninsky, J. 2009; 51 (4): 750-757

Abstract

Seven genomic loci, implicated by single nucleotide polymorphisms (SNPs), have recently been associated with progression to advanced fibrosis (fibrosis risk) in patients with chronic hepatitis C virus. Other variants in these loci have not been examined but may be associated with fibrosis risk independently of or due to linkage disequilibrium with the original polymorphisms.We carried out dense genotyping and association testing of additional SNPs in each of the 7 regions in Caucasian case control samples.We identified several SNPs in the toll-like receptor 4 (TLR4) and syntaxin binding protein 5-like (STXBP5L) loci that were associated with fibrosis risk independently of the original significant SNPs. Haplotypes consisting of these SNPs in TLR4 and STXBP5L were strongly associated with fibrosis risk (global P=3.04 x 10(-5) and 4.49 x 10(-6), respectively).Multiple variants in TLR4 and STXBP5L genes modulate risk of liver fibrosis. These findings are of relevance for understanding the pathogenesis of HCV-induced liver disease in Caucasians and may be extended to other ethnicities as well.

View details for DOI 10.1016/j.jhep.2009.04.027

View details for Web of Science ID 000270749000022

View details for PubMedID 19586676

View details for PubMedCentralID PMC2883297